Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The TRIUMPH-4 Phase 3 data provides the most current safety information: Nausea: 38.1% (9 mg) to 43.2% (12 mg) versus 10.7% placebo Diarrhea: 34.7% (9 mg) to 33.1% (12 mg) versus 13.4% placebo Constipation: 21.8% (9 mg) to 25.0% (12 mg) versus 8.7% placebo Vomiting: 20.4% (9 mg) to 20.9% (12 mg) versus 0% placebo Decreased appetite: 19.0% (9 mg) to 18.2% (12 mg) versus 9.4% placebo The pattern is clear
Choi M, Hegerle N, Nkeze J et al (2020a) The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive Klebsiella pneumoniae in a Multi-Country Collection
Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids
Youll meet with a licensed medical provider who monitors your progress, adjusts treatment as needed, and supports long-term success rather than quick fixes
US$ 29.90
US$ 24.04
US$ 21.61
US$ 24.90
